2022
DOI: 10.3389/fendo.2022.1041027
|View full text |Cite
|
Sign up to set email alerts
|

Sleeve gastrectomy improves lipid dysmetabolism by downregulating the USP20-HSPA2 axis in diet-induced obese mice

Abstract: IntroductionObesity is a metabolic disease accompanied by abnormalities in lipid metabolism that can cause hyperlipidemia, non-alcoholic fatty liver disease, and artery atherosclerosis. Sleeve gastrectomy (SG) is a type of bariatric surgery that can effectively treat obesity and improve lipid metabolism. However, its specific underlying mechanism remains elusive.MethodsWe performed SG, and sham surgery on two groups of diet-induced obese mice. Histology and lipid analysis were used to evaluate operation effect… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 50 publications
0
2
0
Order By: Relevance
“…RUNX1 [395], CDKN2A [403], HSPA2 [423], hsa-mir-132-3p [615], hsa-mir-155-5p [610] and USF2 [616] have been reported to be expressed in Alzheimer’s disease. RUNX1 [449], CAV1 [472], STAT6 [468], CDKN2A [226], HSPA2 [485], hsa-mir-10b-5p [617] and HOXA5 [618] were related to the obesity. RUNX1 [511], CAV1 [534], CACNA1A [543], STAT6 [528], CDKN2A [105], hsa-mir-4516 [619], SRY (sex determining region Y) [620], FOXC1 [621] and PRDM1 [622] might offer useful information for treating hypertension.…”
Section: Discussionmentioning
confidence: 99%
“…RUNX1 [395], CDKN2A [403], HSPA2 [423], hsa-mir-132-3p [615], hsa-mir-155-5p [610] and USF2 [616] have been reported to be expressed in Alzheimer’s disease. RUNX1 [449], CAV1 [472], STAT6 [468], CDKN2A [226], HSPA2 [485], hsa-mir-10b-5p [617] and HOXA5 [618] were related to the obesity. RUNX1 [511], CAV1 [534], CACNA1A [543], STAT6 [528], CDKN2A [105], hsa-mir-4516 [619], SRY (sex determining region Y) [620], FOXC1 [621] and PRDM1 [622] might offer useful information for treating hypertension.…”
Section: Discussionmentioning
confidence: 99%
“…CCR2 [461], FASLG (Fas ligand) [462], CD28 [463], LYZ (lysozyme) [464], CCL5 [465], CCL3 [466], C6 [467], MSR1 [468], HGF (hepatocyte growth factor) [469], VEGFA (vascular endothelial growth factor A) [470], ADM (adrenomedullin) [471], CR2 [472], MAG (myelin associated glycoprotein) [473], CDH1 [474], OLIG2 [475], SEMA4D [476], ADAMTS4 [477], BMP2 [478], ERBB3 [479] and NKX2-2 [480] have been identified as a hub gene in spinal cord injury in several studies. CCR2 [481], FASLG (Fas ligand) [286], CD24 [482], CD28 [483], LYZ (lysozyme) [484], IL7R [485], CCL5 [486], LTF (lactotransferrin) [487], GPNMB (glycoprotein nmb) [488], CTLA4 [489], IRF4 [490], CHIT1 [491], NPY2R [492], TAB2 [131], CD52 [302], CD163 [493], MSR1 [306], HGF (hepatocyte growth factor) [494], TRPM8 [495], TTR (transthyretin) [496], F13A1 [497], ADM (adrenomedullin) [498], COL9A3 [499], ANGPTL4 [500], CHI3L1 [501], BMP8A [502], SREBF1 [503], CDKN1C [504], INSIG1 [505], ATF3 [506], HK2 [507], TF (transferrin) [508], MOG (myelin oligodendrocyte glycoprotein) [509], ADAMTS4 [510], BMP2 [511], HSPA2 [512], LMNA (lamin A/C) [330], HSD11B1 [513], NKX2-2 [514], NHLH2 [433], FGF11 [515], ASPA (aspartoacylase) [336], FASN (fatty acid synthase) [516], PNPLA3 [517], MMP15 [518], CBR1 [519], LRP2 [520], WNT7A [340], GPR142 [521], GPD1 [343], LIPE (lipase E, hormone sensitive type) [522], CNDP1 […”
Section: Discussionmentioning
confidence: 99%